I agree that this site is using cookies. You can find further informations here.
X
Nikkho, Sylvia
56  results:
Search for persons X
?
1

Application of the REVEAL risk score calculator 2.0 in the ..:

Benza, Raymond L. ; Farber, Harrison W. ; Frost, Adaani E....
Respiratory Medicine.  195 (2022)  - p. 106783 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Change in REVEAL Lite 2 risk score predicts outcomes in pat..:

Benza, Raymond L. ; Boucly, Athénaïs ; Farber, Harrison W....
The Journal of Heart and Lung Transplantation.  41 (2022)  3 - p. 411-420 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Pulmonary thromboembolic events in COVID‐19—A systematic li..:

Overton, Paul M. ; Toshner, Mark ; Mulligan, Claire...
Pulmonary Circulation.  12 (2022)  3 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
4

Application of the REVEAL risk score calculator 2.0 in the ..:

Benza, Raymond L. ; Farber, Harrison W. ; Frost, Adaani E....
International Journal of Cardiology.  332 (2021)  - p. 189-192 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Impact of lung morphology on clinical outcomes with riocigu..:

Nathan, Steven D. ; Cottin, Vincent ; Behr, Juergen...
The Journal of Heart and Lung Transplantation.  40 (2021)  6 - p. 494-503 , 2021
Link: https://doi.org/10.1016/..
 
?
6

The Innovative Drug Development Initiative (IDDI) of the Pu..:

Corris, Paul A ; Nikkho, Sylvia ; Fernandes, Peter
Pulmonary Circulation.  10 (2020)  4 - p. 1-1 , 2020
Link: https://doi.org/10.1177/..
 
?
7

Repurposing of medications for pulmonary arterial hypertens..:

Toshner, Mark ; Spiekerkoetter, Edda ; Bogaard, Harm...
Pulmonary Circulation.  10 (2020)  4 - p. 1-12 , 2020
Link: https://doi.org/10.1177/..
 
?
8

Effect of riociguat on pulmonary arterial compliance in the..:

Thenappan, Thenappan ; Al‐Naamani, Nadine ; Ghio, Stefano...
Pulmonary Circulation.  10 (2020)  4 - p. 1-11 , 2020
Link: https://doi.org/10.1177/..
 
?
9

Novel composite clinical endpoints and risk scores used in ..:

Sitbon, Olivier ; Nikkho, Sylvia ; Benza, Raymond...
Pulmonary Circulation.  10 (2020)  4 - p. 1-11 , 2020
Link: https://doi.org/10.1177/..
 
?
10

Clinical trial design in phase 2 and 3 trials for pulmonary..:

Nikkho, Sylvia ; Fernandes, Peter ; White, R. James...
Pulmonary Circulation.  10 (2020)  4 - p. 1-10 , 2020
Link: https://doi.org/10.1177/..
 
?
11

REVEAL risk score in patients with chronic thromboembolic p..:

Benza, Raymond L. ; Farber, Harrison W. ; Frost, Adaani...
The Journal of Heart and Lung Transplantation.  37 (2018)  7 - p. 836-843 , 2018
Link: https://doi.org/10.1016/..
 
?
12

REVEAL risk scores applied to riociguat-treated patients in..:

Benza, Raymond L. ; Farber, Harrison W. ; Frost, Adaani...
The Journal of Heart and Lung Transplantation.  37 (2018)  4 - p. 513-519 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Riociguat in patients with chronic thromboembolic pulmonary..:

McLaughlin, Vallerie V. ; Jansa, Pavel ; Nielsen-Kudsk, Jens E....
BMC Pulmonary Medicine.  17 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
?
14

Riociguat for pulmonary arterial hypertension and chronic t..:

Halank, Michael ; Hoeper, Marius M. ; Ghofrani, Hossein-Ardeschir...
Respiratory Medicine.  128 (2017)  - p. 50-56 , 2017
Link: https://doi.org/10.1016/..
 
?
15

Efficacy and Safety of Inhaled Iloprost in Japanese Patient..:

Saji, Tsutomu ; Myoishi, Masafumi ; Sugimura, Koichiro...
Circulation Journal.  80 (2016)  4 - p. 835-842 , 2016
Link: https://doi.org/10.1253/..
 
1-15